查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
年间契约型资讯服务
商品编码
1646801

现行协议：为交易者提供强大情报 - 生命科学领域的关键交易和联盟资料库

Current Agreements: Powerful Intelligence for Dealmakers - Leading Deals and Alliances Database for the Life Sciences Sector
出版日期: 年间契约型资讯服务 | 出版商: Current Partnering | 英文

价格
简介目录

用于策略决策的综合商业智慧

利用无与伦比的授权、併购和合作协议存取权限，推动您的业务决策

《当前协议》是生命科学产业专业人士寻求深入了解许可、合作、併购和其他策略交易的首要订阅资料库。我们的平台拥有超过 30 年的数千笔交易记录的精心整理檔案，可提供全球生物製药、医疗技术和诊断交易状况的详细资料驱动视图。

为什么要製定现行协议？

我们的平台提供实际合约条款、财务结构和策略交易组成部分的独家存取权，使您能够：

  • 以市场标准为基准 -深入了解行业特定的付款条款、特许权使用费结构和许可费用
  • 竞争策略分析 追踪生物製药、医疗技术和诊断领域的交易活动和策略联盟
  • 发现新机会 - 发现积极参与许可、併购和研发合作的公司
  • 增强您的谈判能力 -利用准确的交易数据来支持您的许可和投资策略
  • 维持业界领先 监控生命科学生态系中不断发展的商业模式、交易结构和新的合作伙伴关係

谁从目前合约中受益？

我们的平台是商业策略、许可和企业发展专业人士的重要资源，其中包括：

  • C 级主管 根据全面的市场情报做出明智的策略决策
  • 业务开发与授权团队 - 确定潜在合作伙伴并确定谈判的基准交易条款
  • 技术转移和智慧财产权经理透过了解标准行业惯例来获得有利的许可协议
  • 投资分析师和财务顾问 -评估新伙伴关係的财务可行性和投资潜力
  • 法律与合规专业人士 - 存取详细的合约条款和监管文件以支持尽职调查
  • 顾问和市场研究人员深入了解影响您所在产业的竞争格局和合约趋势

现行协定的特性

每项现行协议交易记录均采用经过验证的来源资料构建，包括新闻稿、SEC 文件、公司披露和完整的协议文件，以提供完整透明的交易视图。

每个交易设定檔包含：

  • 执行摘要 详细概述主要涉及各方、交易类型及其策略意义。
  • 条款清单 一份结构化摘要，概述交易的关键组成部分，包括财务条款和义务。
  • 详细分类 涵盖产业、治疗领域、地理、发展阶段等多个参数。
  • 财务明细全面揭露预付款、里程碑、特许权使用费和收益分享协议
  • 监管备案和合约 - 查阅官方监管备案和完整合约（如有），以获取更多法律信息

您值得信赖的经过验证的高价值市场情报来源

我们致力于准确性、深度和透明度，确保现行协议中的每个数据点都经过彻底的来源和结构化，以实现最佳的易用性。

无论您是进行竞争分析、寻求许可协议还是为公司交易提供咨询， "当前协议" 都能为您提供在快速发展的生命科学行业取得成功所需的竞争情报。

简介目录

Comprehensive Business Intelligence for Strategic Decision-Making

Empowering Business Decisions with Unparalleled Access to Licensing, M&A, and Partnership Agreements

Current Agreements is the premier subscription database for professionals in the life sciences industry seeking in-depth insights into licensing, collaboration, mergers & acquisitions, and other strategic transactions. With a meticulously curated archive of thousands of deal records spanning over three decades, our platform provides a detailed, data-driven view of the global biopharma, medtech, and diagnostics deal landscape.

Why Choose Current Agreements?

Our platform offers exclusive access to real-world contract terms, financial structures, and strategic deal components, allowing you to:

  • Benchmark Market Standards - Gain critical insights into industry-specific payment terms, royalty structures, and licensing fees.
  • Analyze Competitive Strategies - Track deal trends and strategic alliances across biopharma, medtech, and diagnostics sectors.
  • Identify New Opportunities - Discover companies actively engaging in licensing, M&A, and R&D collaborations within your area of interest.
  • Enhance Negotiation Power - Leverage precise deal data to support your licensing and investment strategies.
  • Stay Ahead of Industry Trends - Monitor evolving business models, deal structures, and emerging partnerships in the life sciences ecosystem.

Who Benefits from Current Agreements?

Our platform is an indispensable resource for professionals involved in business strategy, licensing, and corporate development, including:

  • C-Level Executives - Make informed strategic decisions based on comprehensive market intelligence.
  • Business Development & Licensing Teams - Identify potential partners and benchmark deal terms for negotiations.
  • Technology Transfer & Intellectual Property Managers - Secure advantageous licensing agreements by understanding standard industry practices.
  • Investment Analysts & Financial Advisors - Evaluate the financial viability and investment potential of emerging partnerships.
  • Legal & Compliance Experts - Access detailed contract provisions and regulatory filings to support due diligence efforts.
  • Consultants & Market Researchers - Gain deep insights into the competitive landscape and deal trends shaping the industry.

What Sets Current Agreements Apart?

Each deal record within Current Agreements is structured to provide a complete and transparent view of the transaction, with verified source material including press releases, SEC filings, company disclosures, and full contract documents.

Every deal profile includes:

  • Executive Summary - An overview detailing key parties, transaction type, and strategic significance.
  • Term Sheet - A structured summary outlining critical deal components, including financial terms and obligations.
  • Detailed Categorization - Indexed across multiple parameters such as industry sector, therapeutic focus, geographic region, and development stage.
  • Financial Breakdown - Comprehensive disclosure of upfront payments, milestones, royalties, and revenue-sharing agreements.
  • Regulatory Filings & Contract Documents - Access official regulatory submissions and, where available, full contract texts for an in-depth legal perspective.

A Trusted Source for Verified, High-Value Market Intelligence

Our commitment to accuracy, depth, and transparency ensures that every data point in Current Agreements is meticulously sourced and structured for optimal usability.

Whether you are conducting competitive analysis, pursuing licensing deals, or advising on corporate transactions, Current Agreements provides the critical intelligence necessary to drive success in the rapidly evolving life sciences industry.